"Kaijie" is a nucleic acid test group for brain inflammation/encephalitis pathogens - Taiwan Registration 07c0cc4a18529b1b4a754940f4f448ed
Access comprehensive regulatory information for "Kaijie" is a nucleic acid test group for brain inflammation/encephalitis pathogens in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 07c0cc4a18529b1b4a754940f4f448ed and manufactured by STAT Dx Life S.L;; QIAGEN GMBH. The authorized representative in Taiwan is QIAGEN TAIWAN COMPANY LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is a multiplex nucleic acid qualitative in vitro diagnostic test for the QIAstat-Dx System. This product can simultaneously detect and identify a variety of bacterial, viral, or yeast nucleic acids from cerebrospinal fluid (CSF) samples obtained by lumbar puncture in patients with meningitis and/or encephalitis symptoms and/or symptoms.
C Immunology and microbiology
C.3970 Nucleic acid detection system for the detection and identification of microbial pathogens in cerebrospinal fluid
ๅง่จ่ฃฝ้ ;; QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Mar 14, 2024
Mar 14, 2029